ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing February 26, 4:00 p.m. ET:

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer (JCO: Original Report)
Nicholas Turner, et al.
Request this article

Classification of Background Parenchymal Uptake on Molecular Breast Imaging Using a Convolutional Neural Network (JCO CCI: Original Report) 
Rickey Carter, et al.
Request this article

Publishing February 25, 4:00 p.m. ET:

Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance (JCO: Original Report)
Robert Hamilton, et al.
Request this article

Implementing Precision Medicine in Community-Based Oncology Programs: Three Models (JOP: ASCO Special Article) 
Laura Levit, et al.
Request this article

Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline (JGO: Special Article)
Sarah Temin, et al.
Request this article

Treatment of Patients with Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline (JGO: Special Article)
Sarah Temin, et al.
Request this article

Mobile Device Applications for Electronic Patient Portals in Oncology (JCO CCI: Original Report)
David Gerber, et al.
Request this article

Publishing February 20, 4:00 p.m. ET:

West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer (JCO: Original Report)
Ulrike Nitz, et al.
Request this article

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study (JCO: Original Report)
Carole Soussain, et al.
Request this article

First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers (JCO: Original Report)
Neal Ready, et al.
Request this article

Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study (JCO: Original Report)
Miri Kim, et al.
Request this article

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND—A Double-Blind, Randomized, Phase II Study (JCO: Original Report)
Dean Fennell, et al.
Request this article

Publishing February 19, 4:00 p.m. ET:

Clinical Characteristics and Treatment Outcomes of Patients With Advanced Germ Cell Tumor Treated at a Tertiary Cancer Center in Brazil (JGO: Original Report)
Vitor Fiorin Vasconcellos, et al.
Request this article

Embargo Information

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.